Insiders · MBII

James Boyd

Officer at Marrone Bio Innovations Inc (MBII)

James Boyd has filed 1 insider report with the SEC since February 2021, as officer at Marrone Bio Innovations Inc (MBII). The latest filing, on February 5, 2021, reports grant or award at Marrone Bio Innovations Inc (MBII).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where James Boyd is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Marrone Bio Innovations Inc logo
MBII
Marrone Bio Innovations Inc
Officer309,291Feb 5, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Questions about James Boyd

What is James Boyd's role at Marrone Bio Innovations Inc?
James Boyd reports to the SEC as officer at Marrone Bio Innovations Inc (MBII), according to the latest filing on February 5, 2021.
How many shares does James Boyd own?
After the latest filing that states it, James Boyd directly owned 309,291 shares of Marrone Bio Innovations Inc (MBII). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has James Boyd bought or sold stock recently?
No open-market purchases or sales by James Boyd are on file. The filings report grant or award.
How do I get alerts when James Boyd files?
Follow James Boyd on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by James Boyd (SEC CIK 0001201276). Totals count each trade once, skipping amendments whose original is on file, from Feb 5, 2021 on. View on SEC EDGAR · Get this as JSON